Structure-based discovery of a novel angiotensin-converting enzyme 2 inhibitor.
Identifieur interne : 000B29 ( Ncbi/Checkpoint ); précédent : 000B28; suivant : 000B30Structure-based discovery of a novel angiotensin-converting enzyme 2 inhibitor.
Auteurs : Matthew J. Huentelman [États-Unis] ; Jasenka Zubcevic ; Jose A. Hernández Prada ; Xiaodong Xiao ; Dimiter S. Dimitrov ; Mohan K. Raizada ; David A. OstrovSource :
- Hypertension (Dallas, Tex. : 1979) [ 1524-4563 ] ; 2004.
Descripteurs français
- KwdFr :
- Carboxypeptidases (antagonistes et inhibiteurs), Conception de médicament, Conformation des protéines, Glycoprotéine de spicule des coronavirus, Glycoprotéines membranaires (antagonistes et inhibiteurs), Humains, Hypertension artérielle, Liaison aux protéines, Ligands, Peptidyl-Dipeptidase A, Protéines de l'enveloppe virale (antagonistes et inhibiteurs), Protéines recombinantes, Relation structure-activité, Syndrome respiratoire aigu sévère, Transfection, Virus du SRAS.
- MESH :
- antagonistes et inhibiteurs : Carboxypeptidases, Glycoprotéines membranaires, Protéines de l'enveloppe virale.
- Conception de médicament, Conformation des protéines, Glycoprotéine de spicule des coronavirus, Humains, Hypertension artérielle, Liaison aux protéines, Ligands, Peptidyl-Dipeptidase A, Protéines recombinantes, Relation structure-activité, Syndrome respiratoire aigu sévère, Transfection, Virus du SRAS.
English descriptors
- KwdEn :
- Carboxypeptidases (antagonists & inhibitors), Drug Design, Humans, Hypertension, Ligands, Membrane Glycoproteins (antagonists & inhibitors), Peptidyl-Dipeptidase A, Protein Binding, Protein Conformation, Recombinant Proteins, SARS Virus, Severe Acute Respiratory Syndrome, Spike Glycoprotein, Coronavirus, Structure-Activity Relationship, Transfection, Viral Envelope Proteins (antagonists & inhibitors).
- MESH :
- chemical , antagonists & inhibitors : Carboxypeptidases, Membrane Glycoproteins, Viral Envelope Proteins.
- Drug Design, Humans, Hypertension, Ligands, Peptidyl-Dipeptidase A, Protein Binding, Protein Conformation, Recombinant Proteins, SARS Virus, Severe Acute Respiratory Syndrome, Spike Glycoprotein, Coronavirus, Structure-Activity Relationship, Transfection.
Abstract
Angiotensin-converting enzyme 2 (ACE2) is considered an important therapeutic target for controlling cardiovascular diseases and severe acute respiratory syndrome (SARS) outbreaks. Recently solved high-resolution crystal structures of the apo-bound and inhibitor-bound forms of ACE2 have provided the basis for a novel molecular docking approach in an attempt to identify ACE2 inhibitors and compounds that block SARS coronavirus spike protein-mediated cell fusion. In this study, approximately 140 000 small molecules were screened by in silico molecular docking. In this structure-activity relation study, the molecules with the highest predicted binding scores were identified and assayed for ACE2 enzymatic inhibitory activity and for their ability to inhibit SARS coronavirus spike protein-mediated cell fusion. This approach identified N-(2-aminoethyl)-1 aziridine-ethanamine as a novel ACE2 inhibitor that also is effective in blocking the SARS coronavirus spike protein-mediated cell fusion. Thus, the molecular docking approach resulting in the inhibitory capacity of N-(2-aminoethyl)-1 aziridine-ethanamine provides an attractive small molecule lead compound on which the development of more effective therapeutic agents could be developed to modulate hypertension and for controlling SARS infections.
DOI: 10.1161/01.HYP.0000146120.29648.36
PubMed: 15492138
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002B06
- to stream PubMed, to step Curation: 002B06
- to stream PubMed, to step Checkpoint: 002A10
- to stream Ncbi, to step Merge: 000B29
- to stream Ncbi, to step Curation: 000B29
Links to Exploration step
pubmed:15492138Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Structure-based discovery of a novel angiotensin-converting enzyme 2 inhibitor.</title>
<author><name sortKey="Huentelman, Matthew J" sort="Huentelman, Matthew J" uniqKey="Huentelman M" first="Matthew J" last="Huentelman">Matthew J. Huentelman</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Physiology and Functional Genomics, College of Medicine, University of Florida, Gainesville, Fla 32610, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Physiology and Functional Genomics, College of Medicine, University of Florida, Gainesville, Fla 32610</wicri:regionArea>
<wicri:noRegion>Fla 32610</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Zubcevic, Jasenka" sort="Zubcevic, Jasenka" uniqKey="Zubcevic J" first="Jasenka" last="Zubcevic">Jasenka Zubcevic</name>
</author>
<author><name sortKey="Hernandez Prada, Jose A" sort="Hernandez Prada, Jose A" uniqKey="Hernandez Prada J" first="Jose A" last="Hernández Prada">Jose A. Hernández Prada</name>
</author>
<author><name sortKey="Xiao, Xiaodong" sort="Xiao, Xiaodong" uniqKey="Xiao X" first="Xiaodong" last="Xiao">Xiaodong Xiao</name>
</author>
<author><name sortKey="Dimitrov, Dimiter S" sort="Dimitrov, Dimiter S" uniqKey="Dimitrov D" first="Dimiter S" last="Dimitrov">Dimiter S. Dimitrov</name>
</author>
<author><name sortKey="Raizada, Mohan K" sort="Raizada, Mohan K" uniqKey="Raizada M" first="Mohan K" last="Raizada">Mohan K. Raizada</name>
</author>
<author><name sortKey="Ostrov, David A" sort="Ostrov, David A" uniqKey="Ostrov D" first="David A" last="Ostrov">David A. Ostrov</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2004">2004</date>
<idno type="RBID">pubmed:15492138</idno>
<idno type="pmid">15492138</idno>
<idno type="doi">10.1161/01.HYP.0000146120.29648.36</idno>
<idno type="wicri:Area/PubMed/Corpus">002B06</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002B06</idno>
<idno type="wicri:Area/PubMed/Curation">002B06</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002B06</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002A10</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002A10</idno>
<idno type="wicri:Area/Ncbi/Merge">000B29</idno>
<idno type="wicri:Area/Ncbi/Curation">000B29</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000B29</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Structure-based discovery of a novel angiotensin-converting enzyme 2 inhibitor.</title>
<author><name sortKey="Huentelman, Matthew J" sort="Huentelman, Matthew J" uniqKey="Huentelman M" first="Matthew J" last="Huentelman">Matthew J. Huentelman</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Physiology and Functional Genomics, College of Medicine, University of Florida, Gainesville, Fla 32610, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Physiology and Functional Genomics, College of Medicine, University of Florida, Gainesville, Fla 32610</wicri:regionArea>
<wicri:noRegion>Fla 32610</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Zubcevic, Jasenka" sort="Zubcevic, Jasenka" uniqKey="Zubcevic J" first="Jasenka" last="Zubcevic">Jasenka Zubcevic</name>
</author>
<author><name sortKey="Hernandez Prada, Jose A" sort="Hernandez Prada, Jose A" uniqKey="Hernandez Prada J" first="Jose A" last="Hernández Prada">Jose A. Hernández Prada</name>
</author>
<author><name sortKey="Xiao, Xiaodong" sort="Xiao, Xiaodong" uniqKey="Xiao X" first="Xiaodong" last="Xiao">Xiaodong Xiao</name>
</author>
<author><name sortKey="Dimitrov, Dimiter S" sort="Dimitrov, Dimiter S" uniqKey="Dimitrov D" first="Dimiter S" last="Dimitrov">Dimiter S. Dimitrov</name>
</author>
<author><name sortKey="Raizada, Mohan K" sort="Raizada, Mohan K" uniqKey="Raizada M" first="Mohan K" last="Raizada">Mohan K. Raizada</name>
</author>
<author><name sortKey="Ostrov, David A" sort="Ostrov, David A" uniqKey="Ostrov D" first="David A" last="Ostrov">David A. Ostrov</name>
</author>
</analytic>
<series><title level="j">Hypertension (Dallas, Tex. : 1979)</title>
<idno type="eISSN">1524-4563</idno>
<imprint><date when="2004" type="published">2004</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Carboxypeptidases (antagonists & inhibitors)</term>
<term>Drug Design</term>
<term>Humans</term>
<term>Hypertension</term>
<term>Ligands</term>
<term>Membrane Glycoproteins (antagonists & inhibitors)</term>
<term>Peptidyl-Dipeptidase A</term>
<term>Protein Binding</term>
<term>Protein Conformation</term>
<term>Recombinant Proteins</term>
<term>SARS Virus</term>
<term>Severe Acute Respiratory Syndrome</term>
<term>Spike Glycoprotein, Coronavirus</term>
<term>Structure-Activity Relationship</term>
<term>Transfection</term>
<term>Viral Envelope Proteins (antagonists & inhibitors)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Carboxypeptidases (antagonistes et inhibiteurs)</term>
<term>Conception de médicament</term>
<term>Conformation des protéines</term>
<term>Glycoprotéine de spicule des coronavirus</term>
<term>Glycoprotéines membranaires (antagonistes et inhibiteurs)</term>
<term>Humains</term>
<term>Hypertension artérielle</term>
<term>Liaison aux protéines</term>
<term>Ligands</term>
<term>Peptidyl-Dipeptidase A</term>
<term>Protéines de l'enveloppe virale (antagonistes et inhibiteurs)</term>
<term>Protéines recombinantes</term>
<term>Relation structure-activité</term>
<term>Syndrome respiratoire aigu sévère</term>
<term>Transfection</term>
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en"><term>Carboxypeptidases</term>
<term>Membrane Glycoproteins</term>
<term>Viral Envelope Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr"><term>Carboxypeptidases</term>
<term>Glycoprotéines membranaires</term>
<term>Protéines de l'enveloppe virale</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Drug Design</term>
<term>Humans</term>
<term>Hypertension</term>
<term>Ligands</term>
<term>Peptidyl-Dipeptidase A</term>
<term>Protein Binding</term>
<term>Protein Conformation</term>
<term>Recombinant Proteins</term>
<term>SARS Virus</term>
<term>Severe Acute Respiratory Syndrome</term>
<term>Spike Glycoprotein, Coronavirus</term>
<term>Structure-Activity Relationship</term>
<term>Transfection</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Conception de médicament</term>
<term>Conformation des protéines</term>
<term>Glycoprotéine de spicule des coronavirus</term>
<term>Humains</term>
<term>Hypertension artérielle</term>
<term>Liaison aux protéines</term>
<term>Ligands</term>
<term>Peptidyl-Dipeptidase A</term>
<term>Protéines recombinantes</term>
<term>Relation structure-activité</term>
<term>Syndrome respiratoire aigu sévère</term>
<term>Transfection</term>
<term>Virus du SRAS</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Angiotensin-converting enzyme 2 (ACE2) is considered an important therapeutic target for controlling cardiovascular diseases and severe acute respiratory syndrome (SARS) outbreaks. Recently solved high-resolution crystal structures of the apo-bound and inhibitor-bound forms of ACE2 have provided the basis for a novel molecular docking approach in an attempt to identify ACE2 inhibitors and compounds that block SARS coronavirus spike protein-mediated cell fusion. In this study, approximately 140 000 small molecules were screened by in silico molecular docking. In this structure-activity relation study, the molecules with the highest predicted binding scores were identified and assayed for ACE2 enzymatic inhibitory activity and for their ability to inhibit SARS coronavirus spike protein-mediated cell fusion. This approach identified N-(2-aminoethyl)-1 aziridine-ethanamine as a novel ACE2 inhibitor that also is effective in blocking the SARS coronavirus spike protein-mediated cell fusion. Thus, the molecular docking approach resulting in the inhibitory capacity of N-(2-aminoethyl)-1 aziridine-ethanamine provides an attractive small molecule lead compound on which the development of more effective therapeutic agents could be developed to modulate hypertension and for controlling SARS infections.</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
</list>
<tree><noCountry><name sortKey="Dimitrov, Dimiter S" sort="Dimitrov, Dimiter S" uniqKey="Dimitrov D" first="Dimiter S" last="Dimitrov">Dimiter S. Dimitrov</name>
<name sortKey="Hernandez Prada, Jose A" sort="Hernandez Prada, Jose A" uniqKey="Hernandez Prada J" first="Jose A" last="Hernández Prada">Jose A. Hernández Prada</name>
<name sortKey="Ostrov, David A" sort="Ostrov, David A" uniqKey="Ostrov D" first="David A" last="Ostrov">David A. Ostrov</name>
<name sortKey="Raizada, Mohan K" sort="Raizada, Mohan K" uniqKey="Raizada M" first="Mohan K" last="Raizada">Mohan K. Raizada</name>
<name sortKey="Xiao, Xiaodong" sort="Xiao, Xiaodong" uniqKey="Xiao X" first="Xiaodong" last="Xiao">Xiaodong Xiao</name>
<name sortKey="Zubcevic, Jasenka" sort="Zubcevic, Jasenka" uniqKey="Zubcevic J" first="Jasenka" last="Zubcevic">Jasenka Zubcevic</name>
</noCountry>
<country name="États-Unis"><noRegion><name sortKey="Huentelman, Matthew J" sort="Huentelman, Matthew J" uniqKey="Huentelman M" first="Matthew J" last="Huentelman">Matthew J. Huentelman</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B29 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd -nk 000B29 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= Ncbi |étape= Checkpoint |type= RBID |clé= pubmed:15492138 |texte= Structure-based discovery of a novel angiotensin-converting enzyme 2 inhibitor. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/RBID.i -Sk "pubmed:15492138" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
This area was generated with Dilib version V0.6.33. |